Market Cap 6.74M
Revenue (ttm) 0.00
Net Income (ttm) -15.85M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 18,500
Avg Vol 1,772,226
Day's Range N/A - N/A
Shares Out 1.46M
Stochastic %K 34%
Beta 3.06
Analysts Strong Sell
Price Target $10.00

Company Profile

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of therapies for neurology and oncology diseases in the United States. It develops TPI 287, an investigational chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma, metastatic breast cancer with brain metastases, non-small cell lung cancer, castration-resistant prostate cancer, and neuroblastoma; and Berubicin, an investigational anthracycline chemotherapy agent, which is...

Industry: Biotechnology
Sector: Healthcare
Phone: 800 946 9185
Address:
2100 West Loop South, Suite 900, Houston, United States
WARBUD
WARBUD Jun. 11 at 8:43 PM
$CNSP WARMACHINE BREAKDOWN FOR CNSP WARPLAN ON DEMAND © 🧠 WOD ASK: CNSP ❓ Question: Looking at the WOD data what is your POV for this ticker? Provide a Bull trade ladder. 🕒 2026-06-11T20:34:11.665479+00:00 Here’s the WARBOT tactical read on CNSP, with a bull trade ladder straight from the WOD: POV: CNSP is in a "watch mode"—Sniper system is inactive, so this is strictly a mapping, not a system entry. The setup is classified as WATCH right now based on the INTRADAY Momentum scale. Still, there’s structure here Bulls will care about—and some warning lights. Current Price: $4.72 (after hours) Momentum: High (7.82/10), but mixed signals: MACD and Supertrend are bullish, RSI is neutral, Volume is rising but not explosive. Trend Structure: Symmetrical triangle (confirmed), but price broke below its lower boundary. Compression phase, not breakout. EMA/VWAP: Above short EMAs and VWAP, but EMA 200 (long-term trend) is overhead—resistance above. Sniper Status: INACTIVE. No official bull entry—just a tactical map. This is for scenario planning, not automatic trading. --- Bull Trade Ladder: Immediate Support: $4.71 (previous high and key short-term support—Bulls cannot afford to lose this level). Stand Down/Risk Line: $4.53–$4.56 (Daily Pivot + VWAP). If price drops below here, tactical bull thesis fails short-term. Tighter traders pull the plug at this zone. Hard Invalidation/Washout Floor: $4.40 (1-month, 5-day, and 20-day lows all cluster here). A break below $4.40 means Bulls have lost battlefield control. Ladder Up (Bull Triggers): First Reclaim: $4.85 (previous week’s low—first meaningful bull reclaim. Bulls get traction if this zone gets taken back with volume.) Pattern Confirmation: $5.34–$5.39 (previous week high + bottom context confirmation). $5.34: If price can reclaim last week’s high, it signals a new move. $5.39: Historical bottom confirmation; above here, bottoming structure has confirmation, triangle bear break gets negated. Pattern Invalidation: $5.15 (quick rejection possible—pattern invalidation zone for short-term Bulls). Major Resistance: $5.20 (Fib 61.8%) and $5.34–$5.39. Major Bull Trigger: $8.50 (50-day Fibonacci 23.6%—Big breakout/major move only if price can reclaim this long-range level; far from current price, so this is on the outer campaign map). --- Battle Plan Translation: Bulls Need: To defend $4.71, reclaim $4.85 with volume, and punch through $5.34–$5.39 for trend reversal confirmation. $5.20 is the closest major Fib resistor. Bears Win If: $4.71 is lost, especially on volume, and $4.53 fails as support, putting $4.40 in the crosshairs. Below $4.40, Bulls stand down fully. Trend Read: Constructive for a watch, but not actionable yet. Macro battle is brewing: Bulls have staging ground, but higher timeframes and Sniper call for patience. Bottom Line: Bull road is clearly mapped but not open for attack yet. Key lines—$4.71 (defense), $4.85 (momentum reclaim), $5.34/5.39 (confirmation), $5.20 (Fib choke point). Not a live trade, but a clear plan for when/if the charge comes. No FOMO. Wait and let the range resolve. Bulls don’t fire until $4.85+ is taken back with conviction. If $4.71 cracks, move to the next campaign—don’t average down in the trenches. ------------------------------------------------------------------------------------- 💀 WARMACHINE: 2026-06-11 16:34:11 EDT 📈 WARPLAN: CNSP 🔹WAR: 7.82 / 16 📍 $ 4.72 | +0.11 🟢 | +2.39% 🟢 After Hours: ⚪ 4.72 (0.00 / 0.00%) ━━━━━━ 🔹High: 4.90 🔹Low: 4.40 🔹Open Price: 4.55 🔹Volume: 12.9k 🔹Close Today: 4.72 🔹Prev Close : 4.61 🔹52W High: 10.59 🔹52W Low: 0.66 ━━━━━━ 🎯 WARPLAN: CNSP ━━━━━━ 🔢 Momentum Score: 7.82 / 16 🏁 Confidence Tier: 🔥 Tier 2 - High 💥 Risk Level: MODERATE (Moderate Momentum, Needs Conviction Volume, Weak Trend, High Confidence Setup) 🏷 Tags: Above VAH, Above VWAP, EMA Bullish Stack, MACD 3 Bullish, MACD Histogram Flip, MACD Signal Cross, RSI 15m > 50, RSI 1m > 50, RSI 5m & 15m > 50, Stochastic Cross, Supertrend Multi-Frame ⬆️ Above VWAP 📶 Supertrend Sync (5m + 15m) 🔄 Stochastic Cross (Reversal) 🔺 Above VAH
1 · Reply
marketbull24
marketbull24 Jun. 11 at 7:47 PM
$CNSP @WARBUD whats your POV on this stock?
0 · Reply
NetworkNewsWire
NetworkNewsWire Jun. 8 at 7:22 PM
InvestorNewsBreaks – $CNSP Highlights Oversubscribed $22.5 Million Financing and Growth Strategy in Investor Presentation https://ibn.fm/l4GLJ
0 · Reply
VirtualInvestor
VirtualInvestor Jun. 8 at 1:51 PM
$CNSP In a #VirtualInvestor #WhatThisMeans segment, Steve O’Loughlin, CFO of CNS Pharmaceuticals, discusses the Company’s oversubscribed $22.5 million financing and the momentum behind its strategic transformation. https://vimeo.com/1199387433/bccddeed55?share=copy&fl=sv&fe=ci
0 · Reply
Cns_pharma
Cns_pharma Jun. 8 at 1:33 PM
$CNSP CFO, Steve O’Loughlin, Highlights Company’s Recent $22.5M Financing in Virtual Investor “What This Means” Segment https://vimeo.com/1199387433/bccddeed55?share=copy&fl=sv&fe=ci
0 · Reply
Himan93
Himan93 Jun. 5 at 3:44 PM
Started respecting $CNSP stock after TOXIC 😂 Any idea when is the next reverse split?
0 · Reply
NetworkNewsWire
NetworkNewsWire May. 27 at 3:57 PM
Study Finds Many Young Adults Suffer Sexual Problems After Cancer Treatment $CNSP https://ibn.fm/0luZN #tinygems #stocks
0 · Reply
NetworkNewsWire
NetworkNewsWire May. 26 at 8:04 PM
Study Finds Many Young Adults Suffer Sexual Problems After Cancer Treatment $CNSP #TinyGems #Cancer https://ibn.fm/VjLvG
0 · Reply
Sw1ngb0t
Sw1ngb0t May. 25 at 7:26 PM
$CNSP insider bought... I'm having a hard time believing it won't drop down for a bit though
1 · Reply
ClarityOfPurpose2
ClarityOfPurpose2 May. 22 at 7:57 PM
$CNSP The progress made so far is that they didn’t go bankrupt or get delisted. They have enough money now to keep the lights on and pay the executive salaries and to think big thoughts for a while longer. Until the next reverse split and private placement.
0 · Reply
Latest News on CNSP
CNS Pharmaceuticals Registration statement: Registration filing

May 19, 2026, 8:00 AM EDT - 23 days ago

CNS Pharmaceuticals Registration statement: Registration filing


CNS Pharmaceuticals Quarterly report: Q1 2026

May 14, 2026, 7:00 AM EDT - 4 weeks ago

CNS Pharmaceuticals Quarterly report: Q1 2026


CNS Pharmaceuticals Earnings release: Q1 2026

May 14, 2026, 7:00 AM EDT - 4 weeks ago

CNS Pharmaceuticals Earnings release: Q1 2026


3 Penny Stocks to Watch Now, 5/5/26

2026-05-05T16:22:32.000Z - 5 weeks ago

3 Penny Stocks to Watch Now, 5/5/26

ELPW PN


Why Is CNS Pharmaceuticals Stock (CNSP) Up Today?

2026-05-04T13:58:45.000Z - 5 weeks ago

Why Is CNS Pharmaceuticals Stock (CNSP) Up Today?


CNS Pharmaceuticals Slides: Investor presentation

Apr 22, 2026, 7:00 AM EDT - 7 weeks ago

CNS Pharmaceuticals Slides: Investor presentation


CNS Pharmaceuticals Annual report: Q4 2025

Mar 31, 2026, 7:00 AM EDT - 2 months ago

CNS Pharmaceuticals Annual report: Q4 2025


CNS Pharmaceuticals launches new corporate growth strategy

2026-03-11T12:52:04.000Z - 3 months ago

CNS Pharmaceuticals launches new corporate growth strategy


CNS Pharmaceuticals appoints Lynne Kelley as CMO

2026-03-02T13:42:54.000Z - 3 months ago

CNS Pharmaceuticals appoints Lynne Kelley as CMO


CNS Pharmaceuticals Issues Letter to Shareholders

Jan 27, 2026, 9:00 AM EST - 4 months ago

CNS Pharmaceuticals Issues Letter to Shareholders


CNS Pharmaceuticals Inc trading resumes

2026-01-15T14:45:16.000Z - 5 months ago

CNS Pharmaceuticals Inc trading resumes


CNS Pharmaceuticals Announces CEO Transition

Dec 17, 2025, 7:00 AM EST - 6 months ago

CNS Pharmaceuticals Announces CEO Transition


CNS Pharmaceuticals sees cash runway into 2H26

2025-11-17T14:01:42.000Z - 7 months ago

CNS Pharmaceuticals sees cash runway into 2H26


CNS Pharmaceuticals Quarterly report: Q3 2025

Nov 14, 2025, 4:00 PM EST - 7 months ago

CNS Pharmaceuticals Quarterly report: Q3 2025


CNS Pharmaceuticals Proxy statement: Proxy Filing

Nov 12, 2025, 7:00 AM EST - 7 months ago

CNS Pharmaceuticals Proxy statement: Proxy Filing


CNS Pharmaceuticals Proxy statement: Proxy Filing

Oct 24, 2025, 8:00 AM EDT - 8 months ago

CNS Pharmaceuticals Proxy statement: Proxy Filing


CNS Pharmaceuticals Proxy statement: Proxy Filing

Oct 10, 2025, 8:00 AM EDT - 8 months ago

CNS Pharmaceuticals Proxy statement: Proxy Filing


CNS Pharmaceuticals upgraded to Buy at Maxim on TPI-287 roadmap

2025-09-12T13:05:32.000Z - 9 months ago

CNS Pharmaceuticals upgraded to Buy at Maxim on TPI-287 roadmap


CNS Pharmaceuticals upgraded to Buy from Hold at Maxim

2025-09-12T11:50:09.000Z - 9 months ago

CNS Pharmaceuticals upgraded to Buy from Hold at Maxim


CNS Pharmaceuticals sees cash runway into 2H26

2025-08-15T12:10:34.000Z - 10 months ago

CNS Pharmaceuticals sees cash runway into 2H26


CNS Pharmaceuticals Earnings release: Q2 2025

Aug 14, 2025, 7:00 AM EDT - 10 months ago

CNS Pharmaceuticals Earnings release: Q2 2025


CNS Pharmaceuticals Quarterly report: Q2 2025

Aug 14, 2025, 7:00 AM EDT - 10 months ago

CNS Pharmaceuticals Quarterly report: Q2 2025


CNS Pharmaceuticals Announces Reverse Stock Split

Jul 18, 2025, 8:00 AM EDT - 11 months ago

CNS Pharmaceuticals Announces Reverse Stock Split


CNS Pharmaceuticals Quarterly report: Q1 2025

May 15, 2025, 4:00 PM EDT - 1 year ago

CNS Pharmaceuticals Quarterly report: Q1 2025


CNS Pharmaceuticals Earnings release: Q4 2024

Apr 1, 2025, 4:00 PM EDT - 1 year ago

CNS Pharmaceuticals Earnings release: Q4 2024


CNS Pharmaceuticals Annual report: Q4 2024

Apr 1, 2025, 4:00 PM EDT - 1 year ago

CNS Pharmaceuticals Annual report: Q4 2024


CNS Pharmaceuticals Reports Full Year 2024 Financial Results

Apr 1, 2025, 8:05 AM EDT - 1 year ago

CNS Pharmaceuticals Reports Full Year 2024 Financial Results


CNS Pharmaceuticals Transcript: Investor Update

Dec 11, 2024, 11:30 AM EST - 1 year ago

CNS Pharmaceuticals Transcript: Investor Update


CNS Pharmaceuticals Proxy statement: Proxy Filing

Nov 15, 2024, 7:00 AM EST - 1 year ago

CNS Pharmaceuticals Proxy statement: Proxy Filing


CNS Pharmaceuticals Quarterly report: Q3 2024

Nov 14, 2024, 4:00 PM EST - 1 year ago

CNS Pharmaceuticals Quarterly report: Q3 2024


CNS Pharmaceuticals Proxy statement: Proxy Filing

Oct 28, 2024, 8:00 AM EDT - 1 year ago

CNS Pharmaceuticals Proxy statement: Proxy Filing


CNS Pharmaceuticals Proxy statement: Proxy Filing

Oct 15, 2024, 8:00 AM EDT - 1 year ago

CNS Pharmaceuticals Proxy statement: Proxy Filing


CNS Pharmaceuticals Transcript: Virtual Investor CEO Connect

Aug 26, 2024, 12:00 PM EDT - 1 year ago

CNS Pharmaceuticals Transcript: Virtual Investor CEO Connect


CNS Pharmaceuticals Quarterly report: Q2 2024

Aug 13, 2024, 6:00 PM EDT - 1 year ago

CNS Pharmaceuticals Quarterly report: Q2 2024


CNS Pharmaceuticals Transcript: Investor Update

Jul 30, 2024, 8:30 AM EDT - 2 years ago

CNS Pharmaceuticals Transcript: Investor Update


CNS Pharmaceuticals Press release: Investor Update

Jul 30, 2024, 8:30 AM EDT - 2 years ago

CNS Pharmaceuticals Press release: Investor Update


CNS Pharmaceuticals Registration statement: Registration Filing

Jul 19, 2024, 8:00 AM EDT - 2 years ago

CNS Pharmaceuticals Registration statement: Registration Filing


CNS Pharmaceuticals Registration statement: Registration Filing

Jul 12, 2024, 8:00 AM EDT - 2 years ago

CNS Pharmaceuticals Registration statement: Registration Filing


CNS Pharmaceuticals Registration statement: Registration Filing

Jun 10, 2024, 8:00 AM EDT - 2 years ago

CNS Pharmaceuticals Registration statement: Registration Filing


WARBUD
WARBUD Jun. 11 at 8:43 PM
$CNSP WARMACHINE BREAKDOWN FOR CNSP WARPLAN ON DEMAND © 🧠 WOD ASK: CNSP ❓ Question: Looking at the WOD data what is your POV for this ticker? Provide a Bull trade ladder. 🕒 2026-06-11T20:34:11.665479+00:00 Here’s the WARBOT tactical read on CNSP, with a bull trade ladder straight from the WOD: POV: CNSP is in a "watch mode"—Sniper system is inactive, so this is strictly a mapping, not a system entry. The setup is classified as WATCH right now based on the INTRADAY Momentum scale. Still, there’s structure here Bulls will care about—and some warning lights. Current Price: $4.72 (after hours) Momentum: High (7.82/10), but mixed signals: MACD and Supertrend are bullish, RSI is neutral, Volume is rising but not explosive. Trend Structure: Symmetrical triangle (confirmed), but price broke below its lower boundary. Compression phase, not breakout. EMA/VWAP: Above short EMAs and VWAP, but EMA 200 (long-term trend) is overhead—resistance above. Sniper Status: INACTIVE. No official bull entry—just a tactical map. This is for scenario planning, not automatic trading. --- Bull Trade Ladder: Immediate Support: $4.71 (previous high and key short-term support—Bulls cannot afford to lose this level). Stand Down/Risk Line: $4.53–$4.56 (Daily Pivot + VWAP). If price drops below here, tactical bull thesis fails short-term. Tighter traders pull the plug at this zone. Hard Invalidation/Washout Floor: $4.40 (1-month, 5-day, and 20-day lows all cluster here). A break below $4.40 means Bulls have lost battlefield control. Ladder Up (Bull Triggers): First Reclaim: $4.85 (previous week’s low—first meaningful bull reclaim. Bulls get traction if this zone gets taken back with volume.) Pattern Confirmation: $5.34–$5.39 (previous week high + bottom context confirmation). $5.34: If price can reclaim last week’s high, it signals a new move. $5.39: Historical bottom confirmation; above here, bottoming structure has confirmation, triangle bear break gets negated. Pattern Invalidation: $5.15 (quick rejection possible—pattern invalidation zone for short-term Bulls). Major Resistance: $5.20 (Fib 61.8%) and $5.34–$5.39. Major Bull Trigger: $8.50 (50-day Fibonacci 23.6%—Big breakout/major move only if price can reclaim this long-range level; far from current price, so this is on the outer campaign map). --- Battle Plan Translation: Bulls Need: To defend $4.71, reclaim $4.85 with volume, and punch through $5.34–$5.39 for trend reversal confirmation. $5.20 is the closest major Fib resistor. Bears Win If: $4.71 is lost, especially on volume, and $4.53 fails as support, putting $4.40 in the crosshairs. Below $4.40, Bulls stand down fully. Trend Read: Constructive for a watch, but not actionable yet. Macro battle is brewing: Bulls have staging ground, but higher timeframes and Sniper call for patience. Bottom Line: Bull road is clearly mapped but not open for attack yet. Key lines—$4.71 (defense), $4.85 (momentum reclaim), $5.34/5.39 (confirmation), $5.20 (Fib choke point). Not a live trade, but a clear plan for when/if the charge comes. No FOMO. Wait and let the range resolve. Bulls don’t fire until $4.85+ is taken back with conviction. If $4.71 cracks, move to the next campaign—don’t average down in the trenches. ------------------------------------------------------------------------------------- 💀 WARMACHINE: 2026-06-11 16:34:11 EDT 📈 WARPLAN: CNSP 🔹WAR: 7.82 / 16 📍 $ 4.72 | +0.11 🟢 | +2.39% 🟢 After Hours: ⚪ 4.72 (0.00 / 0.00%) ━━━━━━ 🔹High: 4.90 🔹Low: 4.40 🔹Open Price: 4.55 🔹Volume: 12.9k 🔹Close Today: 4.72 🔹Prev Close : 4.61 🔹52W High: 10.59 🔹52W Low: 0.66 ━━━━━━ 🎯 WARPLAN: CNSP ━━━━━━ 🔢 Momentum Score: 7.82 / 16 🏁 Confidence Tier: 🔥 Tier 2 - High 💥 Risk Level: MODERATE (Moderate Momentum, Needs Conviction Volume, Weak Trend, High Confidence Setup) 🏷 Tags: Above VAH, Above VWAP, EMA Bullish Stack, MACD 3 Bullish, MACD Histogram Flip, MACD Signal Cross, RSI 15m > 50, RSI 1m > 50, RSI 5m & 15m > 50, Stochastic Cross, Supertrend Multi-Frame ⬆️ Above VWAP 📶 Supertrend Sync (5m + 15m) 🔄 Stochastic Cross (Reversal) 🔺 Above VAH
1 · Reply
marketbull24
marketbull24 Jun. 11 at 7:47 PM
$CNSP @WARBUD whats your POV on this stock?
0 · Reply
NetworkNewsWire
NetworkNewsWire Jun. 8 at 7:22 PM
InvestorNewsBreaks – $CNSP Highlights Oversubscribed $22.5 Million Financing and Growth Strategy in Investor Presentation https://ibn.fm/l4GLJ
0 · Reply
VirtualInvestor
VirtualInvestor Jun. 8 at 1:51 PM
$CNSP In a #VirtualInvestor #WhatThisMeans segment, Steve O’Loughlin, CFO of CNS Pharmaceuticals, discusses the Company’s oversubscribed $22.5 million financing and the momentum behind its strategic transformation. https://vimeo.com/1199387433/bccddeed55?share=copy&fl=sv&fe=ci
0 · Reply
Cns_pharma
Cns_pharma Jun. 8 at 1:33 PM
$CNSP CFO, Steve O’Loughlin, Highlights Company’s Recent $22.5M Financing in Virtual Investor “What This Means” Segment https://vimeo.com/1199387433/bccddeed55?share=copy&fl=sv&fe=ci
0 · Reply
Himan93
Himan93 Jun. 5 at 3:44 PM
Started respecting $CNSP stock after TOXIC 😂 Any idea when is the next reverse split?
0 · Reply
NetworkNewsWire
NetworkNewsWire May. 27 at 3:57 PM
Study Finds Many Young Adults Suffer Sexual Problems After Cancer Treatment $CNSP https://ibn.fm/0luZN #tinygems #stocks
0 · Reply
NetworkNewsWire
NetworkNewsWire May. 26 at 8:04 PM
Study Finds Many Young Adults Suffer Sexual Problems After Cancer Treatment $CNSP #TinyGems #Cancer https://ibn.fm/VjLvG
0 · Reply
Sw1ngb0t
Sw1ngb0t May. 25 at 7:26 PM
$CNSP insider bought... I'm having a hard time believing it won't drop down for a bit though
1 · Reply
ClarityOfPurpose2
ClarityOfPurpose2 May. 22 at 7:57 PM
$CNSP The progress made so far is that they didn’t go bankrupt or get delisted. They have enough money now to keep the lights on and pay the executive salaries and to think big thoughts for a while longer. Until the next reverse split and private placement.
0 · Reply
NetworkNewsWire
NetworkNewsWire May. 22 at 7:15 PM
Study Finds That Errors in Brain Cell Division Could Trigger Cancer $CNSP https://ibn.fm/uJ1L4 #biomed #stocks
0 · Reply
Sw1ngb0t
Sw1ngb0t May. 22 at 12:51 AM
$CNSP $VRAX weekly gap always fills... one of my new things. I really like these though
0 · Reply
BillionaireMotion
BillionaireMotion May. 21 at 11:42 PM
$CNSP : You miss all the insane 1,00%+ squeezers recently ??! Make sure ticker EZRA is on watch ! Starting to make a move now and breakout! Looks like shorts could get squeezed hard.. EZRA has 515k shares remaining to the public only. perfect recipe for a monster Would not be shocked at all if it runs soon. Always try to buy them early before the crowd 💎: 👀
0 · Reply
30PERCENT40
30PERCENT40 May. 21 at 10:48 PM
1 · Reply
Sw1ngb0t
Sw1ngb0t May. 20 at 5:52 PM
$CNSP $2.40 then $40... you heard it here first
1 · Reply
Sw1ngb0t
Sw1ngb0t May. 20 at 2:51 PM
$CNSP let it come down to $2.40 then fill the boots
0 · Reply
VirtualInvestor
VirtualInvestor May. 20 at 1:49 PM
$CNSP CEO, Rami Levin, Participates in Virtual Investor CEO Connect Segment Highlighting Company’s Recent Strategic Transformation Progress https://vimeo.com/1193965352/6cf0543a22
0 · Reply
focafoca99
focafoca99 May. 20 at 1:11 PM
$CNSP outlined its recent $22.5 million financing and strategic transformation progress during a virtual CEO Connect segment.
0 · Reply
Sw1ngb0t
Sw1ngb0t May. 20 at 12:13 PM
$CNSP I say $4 will be a good entry... let's see
0 · Reply
Sw1ngb0t
Sw1ngb0t May. 20 at 2:17 AM
$WOK (gotta watch this one...) $CNSP $CMND $ONFO $CMND
1 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT May. 18 at 11:01 AM
$ARTL watch out for armistice they are a self proclaimed long/short fund look what they have done to $CNSP on a 5 yr chart reversed 1/900,000 its toxic vulture finance they make $$$ when the stock goes down
2 · Reply
ClarityOfPurpose2
ClarityOfPurpose2 May. 14 at 10:58 PM
$CNSP You have to wonder whether the same people who gave them the private placement money also helped to subsequently pump the price, then sold their positions, and now are shorting the stock.
0 · Reply